Daclatasvir 30 mg, 60 mg Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 30 mg, 60 mg
Reference Brands: Daklinza® (US & EU)
Category: Hepatitis
Daclatasvir is an effective oral antiviral used to treat chronic Hepatitis C infection by inhibiting the NS5A protein critical for viral replication. Available as 30 mg and 60 mg tablets, it is manufactured under EU-GMP and USFDA standards. Widely used in combination therapies, Daclatasvir supports broad HCV genotype coverage. Ideal for B2B supply, hospital tenders, and licensing, it comes with comprehensive regulatory dossiers enabling quick registration in global markets.
Product Description: Daclatasvir is a potent direct-acting antiviral (DAA) used in the treatment of chronic Hepatitis C virus (HCV) infection. It functions by selectively inhibiting the NS5A protein, a key factor in viral replication and assembly. Available as oral tablets in strengths of 30 mg and 60 mg, Daclatasvir is commonly used in combination with Sofosbuvir or other antivirals for broad genotype coverage. Manufactured under strict EU-GMP and USFDA standards, it is suitable for B2B supply, hospital tenders, and licensing. Comprehensive regulatory dossiers support fast market registration and global distribution.
Daclatasvir — third party manufacturing & bulk supply
Daclatasvir 30 mg, 60 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Daclatasvir is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Daclatasvir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Daclatasvir →Frequently Asked Questions
Related Products
Daclatasvir/ Sofosbuvir
Strength:
Daclatasvir 60 mg + Sofosbuvir 400 mg
Form: Tablet
Reference Brands: Hepcinat Plus (India), Myhep Dvir (India)
View DetailsPegylated Interferon Alpha-1A
Strength:
120 mcg, 150 mcg, 180 mcg
Form: Injection
Reference Brands: Pegasys® (US & EU), PegIntron® (EU)
View DetailsHuman Normal Immunoglobulin
Strength:
IVIG: 5%, 10%, 16%, 20%; SCIG: 20%
Form: (IVIG) & (SCIG)
Reference Brands: Privigen®, Gamunex-C® (EU & US),Flebogamma (LATAM)
View DetailsInterferon Alfa-2B
Strength:
3 million IU/vial, 5 million IU/vial, 10 million IU/vial
Form: Lyophilized Powder for Injection
Reference Brands: Intron A® (EU & US), Roferon-A®(EU), Virafin (Indila)
View DetailsRibavirin
Strength:
Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL
Form: Tablets, Capsules and Oral Solution
Reference Brands: Rebetol®, Copegus®, Virazole®(EU & US)
View DetailsOmbitasvir/Paritaprevir/Ritonavir + Dasabuvir
Strength:
Ombitasvir 12.5 mg / Paritaprevir 75 mg / Ritonavir 50 mg (tablet)+ Dasabuvir 250 mg (tablet)
Form: Tablet
Reference Brands: Viekira Pak® (US); Viekirax® + Exviera® (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers